Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Menlo Park, CA
SEC filing record 1 source field available
Fiscal year end
31 December
AN2 Therapeutics, Inc. has filed 369 SEC EDGAR filings since 24 Sep 2021

SEC filing history

Showing 201-225 of 369 matching filings.

Per page
25
Current page
9
SC 13G/A File 005-93617

SC 13G A AN2

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93617

SC 13G

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93617

JHG PLC AND JHBIF OWN <5%

Filing date
12 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93617

SC 13G/A

Filing date
09 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93617

SC 13G/A

Filing date
09 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
19 Jan 2024
Reporting date
18 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Jan 2024
Reporting date
16 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Jan 2024
Reporting date
16 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
18 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2024
Reporting date
12 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
16 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
16 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jan 2024
Reporting date
10 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Jan 2024
Reporting date
09 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
10 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
10 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Jan 2024
Reporting date
02 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Jan 2024
Reporting date
02 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
02 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
02 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Nov 2023
Reporting date
14 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Nov 2023
Reporting date
14 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
14 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .